201408-35-7 Usage
Uses
Used in Medicinal Chemistry:
3-(3,4-Dimethoxyphenyl)-DL-beta-alaninol is used as a building block in medicinal chemistry for the synthesis of various compounds, particularly those related to the development of pharmaceutical drugs. Its chemical properties and structure make it a useful intermediate in the synthesis of pharmacologically active compounds.
Used in Pharmaceutical Research:
In pharmaceutical research, 3-(3,4-Dimethoxyphenyl)-DL-beta-alaninol is utilized as a key component in the development of new drugs. Its unique structure and properties contribute to the creation of novel therapeutic agents with potential applications in various medical fields.
Used in Organic Chemistry:
3-(3,4-Dimethoxyphenyl)-DL-beta-alaninol also has potential applications in the field of organic chemistry, where it can be used as a reagent in chemical reactions. Its distinct chemical structure allows for its use in various organic synthesis processes, further expanding its utility in chemical research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 201408-35-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,1,4,0 and 8 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 201408-35:
(8*2)+(7*0)+(6*1)+(5*4)+(4*0)+(3*8)+(2*3)+(1*5)=77
77 % 10 = 7
So 201408-35-7 is a valid CAS Registry Number.
InChI:InChI=1/C11H17NO3/c1-14-10-4-3-8(7-11(10)15-2)9(12)5-6-13/h3-4,7,9,13H,5-6,12H2,1-2H3
201408-35-7Relevant academic research and scientific papers
Generation of novel, potent urotensin-II receptor antagonists by alkylation-cyclization of isoindolinone C3-carbanions
Luci, Diane K.,Lawson, Edward C.,Ghosh, Shyamali,Kinney, William A.,Smith, Charles E.,Qi, Jenson,Wang, Yuanping,Minor, Lisa K.,Maryanoff, Bruce E.
experimental part, p. 4958 - 4961 (2009/12/05)
We report a facile alkylation-cyclization reaction involving the isoindolinone C3 position, which resulted in tricyclic derivatives 2 and 10 in 48% and 32% yields, respectively. These novel compounds possess potent urotensin-II receptor antagonist activit
Immunotherapeutic imides/amides
-
, (2008/06/13)
Imide/amide ethers and alcohols are inhibitors of cytokines including tumor necrosis factor α and can be used to combat cachexia, endotoxic shock, arthritis, asthma, and retrovirus replication. A typical embodiment is 3-Phthalimido-3-(3', 4'-dimethoxyphenyl)propan-1-ol.
